SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-178807
Filing Date
2021-06-02
Accepted
2021-06-01 18:10:01
Documents
12
Period of Report
2021-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K d150819d8k.htm   iXBRL 8-K 30488
  Complete submission text file 0001193125-21-178807.txt   151067

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20210528.xsd EX-101.SCH 3056
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20210528_lab.xml EX-101.LAB 17372
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20210528_pre.xml EX-101.PRE 10943
5 EXTRACTED XBRL INSTANCE DOCUMENT d150819d8k_htm.xml XML 3278
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 21986843
SIC: 2834 Pharmaceutical Preparations